Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii
Open Access
- 1 December 2004
- journal article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 10 (12), 1098-1101
- https://doi.org/10.1111/j.1469-0691.2004.00987.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strainJournal of Antimicrobial Chemotherapy, 2004
- Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumanniiClinical Infectious Diseases, 2003
- Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatmentClinical Microbiology & Infection, 2002
- Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problemClinical Microbiology & Infection, 2002
- In Vivo Efficacies of Combinations of β-Lactams, β-Lactamase Inhibitors, and Rifampin against Acinetobacter baumannii in a Mouse Pneumonia ModelAntimicrobial Agents and Chemotherapy, 1999
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumanniiJournal of Antimicrobial Chemotherapy, 1998
- Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic FeaturesClinical Infectious Diseases, 1996
- Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 1996
- Effect of Sulbactam on Infections Caused by Imipenem-ResistantAcinetobacter calcoaceticusBiotypeanitratusThe Journal of Infectious Diseases, 1993